Scripta Insights

During open enrollment, employees have plenty of questions about what their benefits cover and how to use them. It's a good time to answer a few about Scripta, too: what it does, why members may hear from us and where they can turn for help finding a lowe

Lipfendra is officially FDA-approved, giving patients something they haven't had before: an oral PCSK9 inhibitor for lowering LDL, or "bad," cholesterol. As a physician, I'm always glad to see patients get more treatment options. And there's plenty to be

A midyear benefits review can surface a familiar mix of findings: prescription spend is running ahead of forecast, a small number of medications are driving a disproportionate share of cost, or members are not moving to lower-cost options already availabl

Employer care teams are doing exactly what they should be doing: focusing on the member in front of them, not the formulary tier behind them. Pharmacists and prescribers are optimizing for clinical outcomes at the point of care, not plan spend, member cos

By Myea Curry, PHR, SHRM-CP, CPSP Senior Manager, Benefits & Compliance, Agero As benefits professionals, we're often tasked with evaluating new programs and vendors. What's discussed less often is what happens when you inherit an existing benefit. When I

Pharmacy costs are climbing - and for most HR and benefits teams, the usual playbook of Rx cost containment strategies isn't doing enough to keep up. In a recent conversation with Jordan Counts, VP of Pharmacy Services at Quantum Health, we got into the w

What are employers prioritizing when it comes to pharmacy benefits? That's the question I walked into - and came out of with a much clearer answer. As Scripta's Chief Pharmacy Officer, I was invited to speak at this year's Business Group on Health Pharmac

Health plan leaders are asking a consistent set of questions: why pharmacy spend continues to rise despite increasingly sophisticated benefit design, why existing tools aren't consistently influencing decisions at the point of prescribing, and where real,

/PRNewswire/ -- Scripta Insights, the Rx navigation company and Quantum Health, the leading healthcare navigation company, today announced a strategic...

Dr. Paul S. Bradley, MD As Scripta's Chief Medical Officer and an actively practicing clinician currently participating in GLP-1 clinical trials, I've had a front-row seat to one of the most significant shifts in obesity medicine in decades. GLP-1 pills a